Status:
TERMINATED
Long-term Clinical Feasibility of the New Indwelling Provox Vega 20 Voice Prosthesis
Lead Sponsor:
Atos Medical AB
Collaborating Sponsors:
The Netherlands Cancer Institute
Conditions:
Total Laryngectomy
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to investigate long-term clinical feasibility of a new voice prosthesis and insertion system Provox Vega 20 with SmartInserter) for voice rehabilitation after total laryng...
Eligibility Criteria
Inclusion
- total laryngectomy
- use Provox2 voice prosthesis
- at least two prior prosthesis changes
Exclusion
- current puncture problems (f. ex. infection)
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00661570
Start Date
March 1 2008
End Date
March 1 2009
Last Update
March 10 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Netherlands Cancer Institute
Amsterdam, North Holland, Netherlands, 1066CX